Aspen Aerogels, Inc. Reports Third Quarter 2025 Financial Results And Recent Business Highlights
| ($ in millions, except per share amounts – figures may not total due to rounding) | |||
| Metric | YTD Actuals | Prior FY 2025 Outlook | Updated FY 2025 Outlook |
| Revenue | 230 | 297 - 317 | 270 – 280 |
| Net Income (Loss) | (317) | (317) – (307) | (342) – (334) |
| Earnings Per Share (Basic) | (3.85) | (3.86) – (3.73) | (4.15) – (4.05) |
| Adjusted EBITDA | 21 | 35 – 45 | 7 – 15 |
| CAPEX* | 20 | 25 | 25 |
*Capital Expenditures excluding costs related to the Statesboro plant project, which totaled $15.4 million year-to-date as of 9/30/2025
“As we reset our outlook to reflect lower near-term demand in the U.S. EV market, we remain focused on the elements within our control,” said Grant Thoele, Chief Financial Officer and Treasurer.“Throughout 2025, we've taken decisive actions to reduce fixed costs and improve operating efficiency, fortifying the foundation of the business. In addition to strengthening our core markets, we are focused on driving growth through disciplined execution, thoughtful diversification, and developing strategic partnerships.”
The Company's 2025 outlook assumes depreciation and amortization of $22.5 million, stock-based compensation expense of $10.5 million, other expense (net) of $11.5 million, restructuring and demobilization costs of $16.5 million, impairment of property, plant, and equipment of $287.6 million, and weighted average shares outstanding of 82.3 million for the full year.
A reconciliation of net loss to non-GAAP Adjusted EBITDA for the 2025 financial outlook is provided in the financial schedules that are part of this press release. An explanation of this non-GAAP financial measure is also included below under the heading“Non-GAAP Financial Measures.”
Aspen may incur, among other items, additional charges, realize gains or losses, incur financing costs or interest expense, or experience other events in 2025, including those related to supply chain disruptions, or further cost inflation, that could cause actual results to vary materially from this outlook. See Special Note Regarding Forward-Looking and Cautionary Statements below.
Conference Call and Webcast Notification
A conference call with Aspen management to discuss third quarter 2025 results and recent business developments will be held Thursday, November 6, 2025 at 8:30 a.m. EST. During the call, management will respond to questions concerning, but not limited to, Aspen's financial performance, business conditions, and financial outlook. Management's discussion and responses could contain information that has not been previously disclosed.
Shareholders and other interested parties may call +1 (404) 975-4839 (domestic) or +1 (929) 526-1599 (international) and reference conference ID "877424" to participate in the conference call. In addition, the conference call and an accompanying slide presentation will be available live as a listen-only webcast hosted at the Investors section of Aspen's website, .
Following the live event, an archived version of the webcast will be available on Aspen's website for convenient on-demand replay for at least a year. A copy of this press release is posted in the Investors section on Aspen's website.
Non-GAAP Financial Measures
In addition to providing financial measurements based on generally accepted accounting principles in the United States of America ("GAAP"), Aspen provides additional financial metrics that are not prepared in accordance with GAAP ("non-GAAP"). The non-GAAP financial measures included in this press release are Adjusted EBITDA, adjusted net loss and adjusted net loss per share. Management uses these non-GAAP financial measures, in addition to GAAP financial measures, as a measure of operating performance because the non-GAAP financial measures do not include the impact of items that management does not consider indicative of Aspen's core operating performance. In addition, management uses Adjusted EBITDA (i) for planning purposes, including the preparation of Aspen's annual operating budget, (ii) to allocate resources to enhance the financial performance of its business, and (iii) as a performance measure under its bonus plan.
Management believes that these non-GAAP financial measures reflect Aspen's ongoing business in a manner that allows for meaningful comparisons and analysis of trends in its business, as it excludes expenses and gains not reflective of Aspen's ongoing operating results or that may be infrequent and/or unusual in nature. Management also believes that these non-GAAP financial measures provides useful information to investors in understanding and evaluating Aspen's operating results and future prospects in the same manner as management and in comparing financial results across accounting periods and to those of peer companies. These non-GAAP measures may not be comparable to similarly titled measures presented by other companies.
The non-GAAP financial measures do not replace the presentation of Aspen's GAAP financial results and should only be used as a supplement to, not as a substitute for, Aspen's financial results presented in accordance with GAAP. In this press release, Aspen has provided a reconciliation of Adjusted EBITDA to net income (loss), adjusted net loss to net loss and adjusted net loss per share to net loss per share, in each case the most directly comparable GAAP financial measure. Management strongly encourages investors to review Aspen's financial statements and publicly filed reports in their entirety and not rely on any single financial measure.
About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability and electrification solutions. The Company's aerogel technology enables its customers and partners to achieve their own objectives around the global megatrends of resource efficiency, e-mobility and clean energy. Aspen's PyroThin® products enable solutions to thermal runaway challenges within the electric vehicle ("EV") market. The Company's Cryogel® and Pyrogel® products are valued by the world's largest energy infrastructure companies. Aspen's strategy is to partner with world-class industry leaders to leverage its Aerogel Technology Platform® into additional high-value markets. Aspen is headquartered in Northborough, Mass. For more information, please visit .
Special Note Regarding Forward-Looking and Cautionary Statements
This press release and any related discussion contains“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements, including statements relating to Aspen's financial outlook for the full year 2025. These statements are not historical facts but rather are based on Aspen's current expectations, estimates and projections regarding Aspen's business, operations and other factors relating thereto, including with respect to Aspen's financial outlook for the full year 2025. Words such as“may,”“will,”“could,”“would,”“should,”“anticipate,”“predict,”“potential,”“continue,”“expects,”“intends,”“plans,”“projects,”“believes,”“estimates,”“outlook,”“assumes,”“targets,”“opportunity,” and similar expressions are used to identify these forward-looking statements. Such forward-looking statements include statements regarding, among other things, Aspen's beliefs and expectations about revenue, cash flow, gross profit, gross margin, operating margin, net income (loss), Adjusted EBITDA, profitability, capacity, revenue capacity, backlog, costs, expenses, and related increases, decreases, trends or timing, including with respect to Aspen's beliefs and expectations about the EV and energy industrial market; Aspen's potential revenue capacity and gross margins; Aspen's efforts to demobilize its previously planned second manufacturing plant in Statesboro, Georgia; Aspen's efforts to manage the capacity of its manufacturing plant in East Providence, Rhode Island and its external manufacturing facility to meet expected customer demand; current or future trends in the EV and energy infrastructure markets, as well as in adjacent market opportunities such as energy storage applications, electrification applications and other potential adjacent applications; the impact of market trends on Aspen's business; the strength, effectiveness, productivity, costs, potential profitability or other fundamentals of Aspen's business; beliefs about the role of Aspen's technology and opportunities in the EV and energy infrastructure markets, including LNG and Subsea; beliefs about Aspen's ability to provide and deliver products and services to EV and energy infrastructure customers; beliefs about content per vehicle, revenue, costs, expenses, profitability, investments or cash flow associated with Aspen's EV opportunities, including the EV thermal barrier business; and the performance and market acceptance of Aspen's products. All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the following: ongoing uncertainty in the EV and energy infrastructure markets and potential demand for Aspen's products; inability to execute Aspen's long-term growth plan; the right of EV thermal barrier customers to cancel contracts with Aspen at any time and without penalty; any costs, expenses, or investments incurred by Aspen in excess of projections used to develop pricing for Aspen's products; Aspen's inability to create customer or market opportunities for its products; any failure to enforce any of Aspen's patents; the general economic conditions and cyclical demands in the markets that Aspen serves; the impact of changes in government and economic policies, incentives, and tariffs on Aspen's customers, production, sales, cost structure, competitive landscape and results of operations; and the other risk factors discussed under the heading“Risk Factors” in Aspen's Annual Report on Form 10-K for the year ended December 31, 2024 and filed with the Securities and Exchange Commission (“SEC”) on February 27, 2025, as well as any updates to those risk factors filed from time to time in Aspen's subsequent periodic and current reports filed with the SEC. All statements contained in this press release are made only as of the date of this press release. Aspen does not intend to update this information unless required by law.
Investor Relations Contacts:
Neal Baranosky
...
Phone: (508) 691-1111 x 8
Georg Venturatos / Patrick Hall
Gateway Group
...
Phone: (949) 574-3860
| ASPEN AEROGELS, INC. Condensed Consolidated Balance Sheets (Unaudited and in thousands) | ||||||||
| September 30, | December 31, | |||||||
| 2025 | 2024 | |||||||
| (In thousands) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 150,722 | $ | 220,882 | ||||
| Restricted cash | 1,710 | 394 | ||||||
| Accounts receivable, net | 69,149 | 109,104 | ||||||
| Inventories | 43,037 | 47,551 | ||||||
| Prepaid expenses and other current assets | 14,299 | 31,517 | ||||||
| Total current assets | 278,917 | 409,448 | ||||||
| Property, plant and equipment, net | 154,370 | 459,276 | ||||||
| Assets held for sale | 25,504 | - | ||||||
| Operating lease right-of-use assets | 17,557 | 20,854 | ||||||
| Finance lease right-of-use assets | 6,423 | - | ||||||
| Other long-term assets | 8,624 | 5,566 | ||||||
| Total assets | $ | 491,395 | $ | 895,144 | ||||
| Liabilities and Stockholders' Equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 19,098 | $ | 44,361 | ||||
| Accrued expenses | 15,585 | 36,495 | ||||||
| Deferred revenue | 824 | 2,199 | ||||||
| Finance obligation for sale and leaseback transactions | 4,265 | 4,028 | ||||||
| Operating lease liabilities | 3,243 | 3,279 | ||||||
| Finance lease liabilities | 1,724 | - | ||||||
| Long term debt - current portion | 26,000 | 19,750 | ||||||
| Total current liabilities | 70,739 | 110,112 | ||||||
| Revolving line of credit | 14,252 | 42,131 | ||||||
| Long term debt | 70,090 | 94,961 | ||||||
| Finance obligation for sale and leaseback transactions long-term | 6,133 | 10,087 | ||||||
| Operating lease liabilities long-term | 20,745 | 23,148 | ||||||
| Finance lease liabilities long-term | 3,703 | - | ||||||
| Total liabilities | 185,662 | 280,439 | ||||||
| Stockholders' equity: | ||||||||
| Total stockholders' equity | 305,733 | 614,705 | ||||||
| Total liabilities and stockholders' equity | $ | 491,395 | $ | 895,144 |
| ASPEN AEROGELS, INC. Consolidated Statements of Operations (Unaudited and in thousands, except share and per share data) | ||||||||||||||||
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (In thousands, except share and per share data) | ||||||||||||||||
| Revenue | $ | 73,017 | $ | 117,340 | $ | 229,764 | $ | 329,611 | ||||||||
| Cost of revenue | 52,218 | 68,297 | 160,837 | 193,847 | ||||||||||||
| Gross profit | 20,799 | 49,043 | 68,927 | 135,764 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Research and development | 2,494 | 4,591 | 10,621 | 13,645 | ||||||||||||
| Sales and marketing | 6,553 | 9,306 | 21,885 | 27,130 | ||||||||||||
| General and administrative | 13,532 | 17,746 | 40,402 | 52,465 | ||||||||||||
| Restructuring and demobilization costs | 1,568 | - | 16,296 | - | ||||||||||||
| Impairment of property, plant and equipment | - | - | 287,567 | 2,702 | ||||||||||||
| Total operating expenses | 24,147 | 31,643 | 376,771 | 95,942 | ||||||||||||
| Income (loss) from operations | (3,348 | ) | 17,400 | (307,844 | ) | 39,822 | ||||||||||
| Other income (expense) | ||||||||||||||||
| Interest expense, convertible note - related party | - | (1,469 | ) | - | (7,550 | ) | ||||||||||
| Interest expense | (2,973 | ) | (1,147 | ) | (8,015 | ) | (883 | ) | ||||||||
| Loss on extinguishment of debt | - | (27,487 | ) | - | (27,487 | ) | ||||||||||
| Other income | 581 | - | 1,711 | - | ||||||||||||
| Total other expense | (2,392 | ) | (30,103 | ) | (6,304 | ) | (35,920 | ) | ||||||||
| Income (loss) before income tax expense | (5,740 | ) | (12,703 | ) | (314,148 | ) | 3,902 | |||||||||
| Income tax expense | (594 | ) | (267 | ) | (2,491 | ) | (1,889 | ) | ||||||||
| Net income (loss) | $ | (6,334 | ) | $ | (12,970 | ) | $ | (316,639 | ) | $ | 2,013 | |||||
| Net income (loss) per share: | ||||||||||||||||
| Basic | $ | (0.08 | ) | $ | (0.17 | ) | $ | (3.85 | ) | $ | 0.03 | |||||
| Diluted | $ | (0.08 | ) | $ | (0.17 | ) | $ | (3.85 | ) | $ | 0.03 | |||||
| Weighted-average common shares outstanding: | ||||||||||||||||
| Basic | 82,399,599 | 76,261,294 | 82,216,027 | 76,402,123 | ||||||||||||
| Diluted | 82,399,599 | 76,261,294 | 82,216,027 | 79,149,193 |
Analysis of Cash Flow
The following table summarizes our cash flows for the periods indicated.
| Nine Months Ended | ||||||||
| September 30, | ||||||||
| 2025 | 2024 | |||||||
| (In thousands) | ||||||||
| Net cash provided by (used in): | ||||||||
| Operating activities | $ | 16,737 | $ | 9,865 | ||||
| Investing activities | (34,985 | ) | (71,511 | ) | ||||
| Financing activities | (50,596 | ) | 35,558 | |||||
| Net decrease in cash | (68,844 | ) | (26,088 | ) | ||||
| Cash, cash equivalents and restricted cash at beginning of period | 221,276 | 139,971 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 152,432 | $ | 113,883 |
| Three Months Ended | ||||||||||||
| March 31, 2025 | June 30, 2025 | September 30, 2025 | ||||||||||
| (In thousands) | ||||||||||||
| Net cash provided by (used in): | ||||||||||||
| Operating activities | $ | 5,632 | $ | (3,930 | ) | $ | 15,035 | |||||
| Investing activities | (12,998 | ) | (12,885 | ) | (9,102 | ) | ||||||
| Financing activities | (21,477 | ) | (7,586 | ) | (21,533 | ) | ||||||
| Net (decrease) increase in cash | (28,843 | ) | (24,401 | ) | (15,600 | ) | ||||||
| Cash, cash equivalents and restricted cash at beginning of period | 221,276 | 192,433 | 168,032 | |||||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 192,433 | $ | 168,032 | $ | 152,432 |
Reconciliation of Non-GAAP Financial Measures
The following tables present a reconciliation of the non-GAAP financial measure included in this press release to the most directly comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net income (loss)
We define Adjusted EBITDA as net income (loss) before interest expense, taxes, depreciation, amortization, stock-based compensation expense and other items, which occur from time to time and which we do not believe are indicative of our core operating performance.
For the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| (In thousands) | ||||||||||||||||
| Net income (loss) | $ | (6,334 | ) | $ | (12,970 | ) | $ | (316,639 | ) | $ | 2,013 | |||||
| Depreciation and amortization | 5,393 | 5,321 | 16,981 | 17,093 | ||||||||||||
| Stock-based compensation | 2,642 | 2,630 | 7,927 | 10,307 | ||||||||||||
| Other expense | 2,392 | 2,616 | 6,304 | 8,433 | ||||||||||||
| Income tax expense | 594 | 267 | 2,491 | 1,889 | ||||||||||||
| Loss on extinguishment of debt | - | 27,487 | - | 27,487 | ||||||||||||
| Restructuring and demobilization costs | 1,568 | - | 16,296 | - | ||||||||||||
| Impairment of property, plant and equipment | - | - | 287,567 | - | ||||||||||||
| Adjusted EBITDA | $ | 6,255 | $ | 25,351 | $ | 20,927 | $ | 67,222 |
Other Information
The following tables reconcile net income (loss) and net income (loss) per share to adjusted net income (loss) and adjusted net income (loss) per share for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended | ||||||||||||||||
| September 30, 2025 | September 30, 2024 | |||||||||||||||
| Amount | Per Share | Amount | Per Share | |||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||
| Net loss | $ | (6,334 | ) | $ | (0.08 | ) | $ | (12,970 | ) | $ | (0.17 | ) | ||||
| Restructuring and demobilization costs | 1,568 | 0.02 | - | - | ||||||||||||
| Impairment of property, plant and equipment | - | - | - | - | ||||||||||||
| Adjusted Net Loss | $ | (4,766 | ) | $ | (0.06 | ) | $ | (12,970 | ) | $ | (0.17 | ) |
| Nine Months Ended | ||||||||||||||||
| September 30, 2025 | September 30, 2024 | |||||||||||||||
| Amount | Per Share | Amount | Per Share | |||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||
| Net income (loss) | $ | (316,639 | ) | $ | (3.85 | ) | $ | 2,013 | $ | 0.03 | ||||||
| Restructuring and demobilization costs | 16,296 | 0.20 | - | - | ||||||||||||
| Impairment of property, plant and equipment | 287,567 | 3.50 | - | - | ||||||||||||
| Adjusted Net Income (Loss) | $ | (12,776 | ) | $ | (0.16 | ) | $ | 2,013 | $ | 0.03 |
For the 2025 full year financial outlook:
| Current Outlook | ||||||||
| Year Ending | ||||||||
| December 31, 2025 | ||||||||
| Low | High | |||||||
| (In thousands) | ||||||||
| Net loss | $ | (341,600 | ) | $ | (333,600 | ) | ||
| Depreciation and amortization | 22,500 | 22,500 | ||||||
| Stock-based compensation | 10,500 | 10,500 | ||||||
| Other expense, net | 11,500 | 11,500 | ||||||
| Restructuring and demobilization costs | 16,500 | 16,500 | ||||||
| Impairment of property, plant and equipment | 287,600 | 287,600 | ||||||
| Adjusted EBITDA | $ | 7,000 | $ | 15,000 |
| Prior Outlook | ||||||||
| Year Ending | ||||||||
| December 31, 2025 | ||||||||
| Low | High | |||||||
| (In thousands) | ||||||||
| Net loss | $ | (316,805 | ) | $ | (306,805 | ) | ||
| Depreciation and amortization | 24,789 | 24,789 | ||||||
| Stock-based compensation | 10,284 | 10,284 | ||||||
| Other expense, net | 11,109 | 11,109 | ||||||
| Restructuring and demobilization costs | 17,728 | 17,728 | ||||||
| Impairment of property, plant and equipment | 287,567 | 287,567 | ||||||
| Adjusted EBITDA | $ | 34,672 | $ | 44,672 |

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment